Abstract 3132: Inhibition of the integrin αVβ3 improves the effect of bexarotene in the treatment of cutaneous T-cell lymphoma (CTCL)
Florencia Cayrol(Cornell University), Graciela Cremaschi(Pontificia Universidad Católica Argentina), Alejandra Paulazo, Mercedes Debernardi(Consejo Nacional de Investigaciones Científicas y Técnicas), Leandro Cerchietti(Cornell University), Helena Sterle(Pontificia Universidad Católica Argentina), Victoria Revueta(Cornell University), María C. Díaz Flaqué(Pontificia Universidad Católica Argentina)
Cited by 0
Related Papers
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors
|Nature Communications|2017|108
The metabolic adaptation evoked by arginine enhances the effect of radiation in brain metastases
|Science Advances|2021|42
Immunomodulatory role of histamine H4 receptor in breast cancer
|British Journal of Cancer|2018|35
Oncogenic HSP90 Facilitates Metabolic Alterations in Aggressive B-cell Lymphomas
|Cancer Research|2021|28
Thyroid status modulates T lymphoma growth via cell cycle regulatory proteins and angiogenesis
|Journal of Endocrinology|2014|22